NATICK, Mass.-- Boston Scientific Corporation (NYSE: BSX ) today announced the sale of Boston Scientific Santa Rosa Corp., formerly known as TriVascular, Inc., to TV2 Holding Company, a privately held company based in Santa Rosa, California. Boston Scientific Santa Rosa Corp. holds equipment and intellectual property related to the TriVascular endovascular aortic repair (EVAR) program. Terms of the sale include $30 million in cash paid at closing to Boston Scientific and a warrant allowing Boston Scientific to purchase a minority interest in TV2.
Full text >>
Wednesday, April 2, 2008
Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment